The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Dolmatil 400mg Film-Coated Tablets

400 milligram(s) Film-coated tablet

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/147/002

Main Information

Trade NameDolmatil 400mg Film-Coated Tablets
Active SubstancesSulpiride
Strength400 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/147/002

Group Information

ATC CodeN05AL Benzamides
N05AL01 sulpiride


Licence Issued23/03/1990
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back